tiprankstipranks
Analyst Profile
Followed by 81 other investors
.
Douglas Loe

Douglas Loe

Leede Jones Gable
Wall Street Analyst
Ranked #324 out of 8,047 Analysts on TipRanks (#426 out of 21,521 overall experts)

Success Rate

50%
70 out of 140 Profitable Transactions

Average Return

28.00%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark
If you copied Douglas Loe's ratings since 2010 and opened each position for the duration of 1 Year:
50.00% of your transactions would have been profitable with an average return of 28.0%

Stock Rating Distribution

201Ratings
87.06% Buy
12.44% Hold
0.50% Sell
Distribution of Douglas Loe's ratings

Additional Information

Main Sector:Healthcare
Geo Coverage:
United StatesUS Market
CanadaCanadian Market

Best Rating

Stock:
Sernova Corp
(SVA)
Rating Type:Buy
Dates:Feb 10, 2020 - Feb 10, 2021
Gain:800.00%
The most profitable rating made by Douglas Loe

Douglas Loe's Stock Coverage

Company Name
Date
Position
Action
Price Target
Success Rate
Avg Return
No. of Ratings
TTHI
Transition Therapeutics
Sep 17, 2010
Hold
Downgraded
0.00%
1
IMRIS
Mar 19, 2013
Buy
Reiterated
0%
-40.70%
2
NVDQ
Novadaq
Apr 30, 2013
Buy
Reiterated
100%
+64.70%
3
SPHS
Sophiris Bio
Jun 10, 2016
Buy
Reiterated
50%
-21.55%
2
RepliCel Life Sciences
Feb 28, 2017
Buy
Reiterated
$2.15
(2557.60% Upside)
0%
-51.10%
1
TSTIF
TSO3 Inc
Jan 09, 2019
Buy
Reiterated
0%
-43.30%
2
Arbutus Biopharma
Oct 07, 2019
Hold
Downgraded
$1.00
(-60.00% Downside)
67%
+88.00%
4
CORV
Correvio Pharma
Mar 16, 2020
Hold
Assigned
0%
-78.90%
3
Claritas Pharmaceuticals
Jun 16, 2020
Buy
Reiterated
100%
+46.25%
2
Theratechnologies
Jul 15, 2020
Buy
Reiterated
$8.61
(296.75% Upside)
57%
+14.64%
9
List of latest recommendations made by Douglas Loe. Click to expand and see Douglas Loe's performance on a particular stock
Disclaimer: TipRanks collects ratings and price targets of analysts by scanning publicly available reports on financial websites and by receiving reports directly from the analysts or from our users. The information displayed and the Analyst Profile statistics might not be accurate, complete, or up to date. The analyst ratings provided are entirely at the sole responsibility of the of the source publication. TipRanks holds no liability over the analysts' information, price targets, ratings or opinions expressed on the site.
Are We Missing a Rating?
Send us the equity research you are getting and become a Power User
Learn More